MetaCap

Enanta Pharmaceuticals Statistics

NASDAQ: ENTAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

7.62-0.36 (-4.51%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Enanta Pharmaceuticals by the numbers

Enanta Pharmaceuticals has a market capitalization of $222.2 million based on 29.16M shares outstanding. With trailing EPS of $-2.35, Enanta Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 33.6% below its 50-day average and 41.3% below its 200-day average.

Average daily trading volume is 287.81K shares, or about $2.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ENTA valuation vs. peer median

ENTA compared with the median of 8 peer companies
MetricENTAPeer medianDifference
Market cap$222.19M$216.96M+2%
Avg. volume287.81K954.92K-70%

Peer median across 8 companies: IMRX, RCKT, KROS, PYXS, ARCT, CYPH, VNDA, CAMP.

Valuation

Market cap
$222.19M
Price / sales (latest FY)
3.53
EPS (TTM)
$-2.35

Price and trading

Previous close
7.98
Open
7.82
Day range
7.56 – 8.06
52-week range
7.56 – 17.15
52-week change
-40.14%
Beta
—
Volume
457.63K

Dividends and events

Annual dividend
None
Next earnings date
Nov 16, 2026

Additional statistics

Market Cap
222.19M
Forward Pe
-3.56
Eps
-2.35
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
17.15
Week52 Low
7.56
Avg Volume
287.81K
Shares Outstanding
29.16M
Ma50
11.48
Ma200
12.98
Earnings Date
Nov 16, 2026
Pct From52w High
-55.57%
Pct From52w Low
0.79%

Related